WILCOX GARY 4
4 · Cocrystal Pharma, Inc. · Filed Jun 24, 2020
Insider Transaction Report
Form 4
WILCOX GARY
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2020-06-22+200,000→ 200,000 totalExercise: $1.33Exp: 2030-06-22→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year.
- [F2]The stock options vest as follows: 100,000 stock options will vest on the one year anniversary of the grant date and the remaining 100,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021.